Milk-derived bioactive peptides inhibit human endothelial-monocyte interactions via PPAR-γ dependent regulation of NF-κB.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 4308943)

Published in J Inflamm (Lond) on January 20, 2015

Authors

Simone Marcone1, Karen Haughton2, Paul J Simpson3, Orina Belton2, Desmond J Fitzgerald4

Author Affiliations

1: FHI, Food for Health Ireland, University College Dublin, Dublin, Ireland ; School of Medicine and Medical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin, 4 Ireland.
2: School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland.
3: Teagasc, Biotechnology Centre, Moorepark, Fermoy, County Cork Ireland.
4: School of Medicine and Medical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin, 4 Ireland.

Articles cited by this

The nuclear receptor superfamily: the second decade. Cell (1995) 24.99

A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med (1997) 19.93

Endothelial function and dysfunction: testing and clinical relevance. Circulation (2007) 6.47

IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem (1999) 5.16

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature (2000) 4.66

Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation (1997) 4.41

Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet (1998) 3.97

Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol (2002) 3.59

Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry (1999) 3.07

Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res (2000) 3.02

Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc Med (2008) 2.22

Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall. Circ Res (2007) 2.15

Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. Circulation (2000) 2.15

The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: an overview of the evidence. Lipids (2010) 1.96

Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction. Arterioscler Thromb Vasc Biol (1999) 1.72

Food-derived peptides with biological activity: from research to food applications. Curr Opin Biotechnol (2007) 1.70

The ubiquitin-dependent proteolytic system and other potential targets for the modulation of nuclear factor-kB (NF-kB). Curr Drug Targets (2000) 1.61

Endothelial dysfunction: from molecular mechanisms to measurement, clinical implications, and therapeutic opportunities. Antioxid Redox Signal (2008) 1.53

A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr (1996) 1.30

Molecular basis for the direct inhibition of AP-1 DNA binding by 15-deoxy-Delta 12,14-prostaglandin J2. J Biol Chem (2003) 1.28

Milk products, insulin resistance syndrome and type 2 diabetes. J Am Coll Nutr (2009) 1.28

Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis. Biochem Pharmacol (2000) 1.26

Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790. J Dairy Sci (1996) 1.24

Inflammation and the development of atherosclerosis. J Atheroscler Thromb (2011) 1.18

Lipoprotein cholesterol and atherosclerosis. Curr Mol Med (2001) 1.13

Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790. J Dairy Sci (1994) 1.12

Pathophysiology of atherosclerosis: the role of inflammation. Curr Pharm Des (2011) 1.12

Antibacterial and immunostimulating casein-derived substances from milk: casecidin, isracidin peptides. Food Chem Toxicol (1996) 1.12

Putting microbes to work: dairy fermentation, cell factories and bioactive peptides. Part II: bioactive peptide functions. Biotechnol J (2007) 1.09

The impact of genetic polymorphisms on the protein composition of ruminant milks. Reprod Nutr Dev (2003) 1.08

Control of vascular cell proliferation and migration by PPAR-gamma: a new approach to the macrovascular complications of diabetes. Diabetes Care (2001) 1.07

Bioactive peptides and proteins. Adv Food Nutr Res (2003) 1.06

Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats. J Physiol Pharmacol (2001) 1.06

Multifunctional peptides encrypted in milk proteins. Biofactors (2004) 1.03

Database of biologically active peptide sequences. Nahrung (1999) 1.02

Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J Nutr (1996) 0.99

Biofunctional peptides from milk proteins: mineral binding and cytomodulatory effects. Curr Pharm Des (2003) 0.99

Biochemical properties of regulatory peptides derived from milk proteins. Biopolymers (1997) 0.99

α-Enolase expressed on the surfaces of monocytes and macrophages induces robust synovial inflammation in rheumatoid arthritis. J Immunol (2012) 0.99

Troglitazone, a PPAR-gamma activator prevents endothelial cell adhesion molecule expression and lymphocyte adhesion mediated by TNF-alpha. BMC Physiol (2005) 0.98

Long-term intervention with Lactobacillus helveticus fermented milk reduces augmentation index in hypertensive subjects. Eur J Clin Nutr (2010) 0.98

Effects of stage of lactation, milk protein genotype and body condition at calving on protein composition and renneting properties of bovine milk. J Dairy Res (1997) 0.96

Kappacin, a novel antibacterial peptide from bovine milk. Antimicrob Agents Chemother (2001) 0.95

Trans- but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-κB activation and peroxisome proliferator-activated receptor-gamma upregulation. J Immunol (2010) 0.94

Atherosclerosis: a classic inflammatory disease. Int J Immunopathol Pharmacol (2012) 0.93

Bioactive substances in milk with properties decreasing risk of cardiovascular diseases. Br J Nutr (2000) 0.93

Seasonal and lactational influences on bovine milk composition in New Zealand. J Dairy Res (1998) 0.92

Retinoid X receptor agonists impair arterial mononuclear cell recruitment through peroxisome proliferator-activated receptor-γ activation. J Immunol (2012) 0.90

The potential role of milk-derived peptides in cardiovascular disease. Food Funct (2011) 0.89

Cardiovascular activity of milk casein-derived tripeptides and plant sterols in spontaneously hypertensive rats. J Physiol Pharmacol (2009) 0.89

Dual function of troglitazone in ICAM-1 gene expression in human vascular endothelium. Biochem Biophys Res Commun (2001) 0.88

The ACE inhibitory dipeptide Met-Tyr diminishes free radical formation in human endothelial cells via induction of heme oxygenase-1 and ferritin. J Nutr (2006) 0.88

A cyclopentenone prostaglandin activates mesangial MAP kinase independently of PPARgamma. Biochem Biophys Res Commun (2001) 0.88

Peroxisome proliferator-activated receptor γ agonist troglitazone inhibits high mobility group box 1 expression in endothelial cells via suppressing transcriptional activity of nuclear factor κB and activator protein 1. Shock (2011) 0.87

A whey protein hydrolysate promotes insulinotropic activity in a clonal pancreatic β-cell line and enhances glycemic function in ob/ob mice. J Nutr (2013) 0.86

Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme. Hypertens Res (2007) 0.86

Characterization of an antithrombotic peptide from kappa-casein in newborn plasma after milk ingestion. Br J Nutr (1995) 0.86

Antihypertensive effect of tryptic hydrolysate of milk casein in spontaneously hypertensive rats. Comp Biochem Physiol C (1990) 0.85

Exendin-4, a GLP-1 receptor agonist, interacts with proteins and their products of digestion to suppress food intake in rats. J Nutr (2003) 0.83

Identification of a NFκB inhibitory peptide from tryptic β-casein hydrolysate. Food Chem (2014) 0.83

Technological options for the production of health-promoting proteins and peptides derived from milk and colostrum. Curr Pharm Des (2007) 0.83

Variability in true protein, casein, nonprotein nitrogen, and proteolysis in high and low somatic cell milks. J Dairy Sci (1987) 0.82

A comparison of the composition, coagulation characteristics and cheesemaking capacity of milk from Friesian and Jersey dairy cows. J Dairy Res (2004) 0.81

Monocytes from sickle cell disease patients induce differential pulmonary endothelial gene expression via activation of NF-κB signaling pathway. Mol Immunol (2012) 0.80

Study of platelet adhesion in patients with uncomplicated hypertension. J Hypertens (1996) 0.79

The effects of the calcium antagonist amlodipine on blood pressure and platelet aggregation in hypertensive patients. Postgrad Med J (1991) 0.76